How to Save $100 Billion
The Pharmaceutical Care Management Association (PCMA) sent a letter to the Joint Select Committee on Deficit Reduction that outlined greater use of pharmacy benefit management (PBM) tools to save more than $100 billion in prescription drug costs over the next 10 years.
The Pharmaceutical Care Management Association (PCMA) sent a letter to the Joint Select Committee on Deficit Reduction that outlined greater use of pharmacy benefit management (PBM) tools to save more than $100 billion in prescription drug costs over the next 10 years.
“Policymakers looking for savings solutions should consider modernizing Medicaid pharmacy,” says Charles Cote PCMA assistant vice president, Strategic Communications. “Currently, the Medicaid fee-for-service program uses fewer generic drugs and pays drugstores more than double the pharmacy fees that Medicare or private insurers pay. Over the next decade, the federal government alone could save $21 billion - without cutting benefits or payments to doctors and hospitals - by modernizing Medicaid pharmacy benefits and utilizing proven PBM tools.”
In addition to modernizing Medicaid pharmacy, the options PCMA recommended to the Joint Select Committee included maximizing generic and therapeutic substitution in Part D, expediting the approval of biogenerics, allowing Part D plans to negotiate greater discounts on all drugs, banning a tax deduction for direct-to-consumer drug advertising, encouraging chronic care pharmacy and home delivery, and banning pay-for-delay drug settlements between brand-name drug companies and generic manufacturers.
Today, the clade 2b outbreak has reached alarming proportions, with over 94,000 confirmed cases reported across 117 countries, including significant numbers in the U.S. and Brazil, and up to 103 deaths. The virus has been found to affect younger men who have sex with men, who are linked to high rates of HIV co-infection.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
